Dr. Kenneth Tsai, M.D., Ph.D., is a board-certified dermatologist and dermatopathologist leading a NIH funded research program focused on cutaneous squamous cell carcinoma, signaling pathways in melanoma and responses to therapy, and biomarker development for skin cancer risk and prediction of therapeutic responses. Dr. Tsai is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He leads a new translational research effort to address unmet needs in high-risk non-melanoma skin cancers within the Melanoma and Skin Cancer Center of Excellence.
Dr. Tsai received his Ph.D. in biology from the Massachusetts Institute of Technology and his M.D. from Harvard Medical School. He completed an internship in Internal Medicine and clinical residency training in Dermatology at Massachusetts General Hospital, and a clinical fellowship in dermatopathology at Beth Israel Deaconess Hospital.